Concepedia

Author

Candace X. Moore

Amplyx Pharmaceuticals (United States)ORCID

Also Known As

C X Moore, C. Moore, C. X. Moore, C.X. Moore, Candace Moore, Candace X. Moore

16

Publications

1K

Citations

10

H-Index

45

Concepts

All Affiliations

Amplyx Pharmaceuticals (United States)
CX

About

Candace X. Moore is an author at Amplyx Pharmaceuticals (United States) specializing in physiology, medicine, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

875

2

Health Sciences

4

4

473

3

Biochemistry

3

3

185

4

Cell Biology

2

2

234

5

Social Sciences

1

1

99

Candace X. Moore

×

9

Publications

916

Citations

9

H-Index

YearCitations

Effects of PYY[3–36] in rodent models of diabetes and obesity

Richard Pittner, Candace X. Moore, Sunil Bhavsar,

International Journal of Obesity

2004

219

Co-secretion of amylin and insulin from cultured islet β-cells: Modulation by nutrient secretagogues, islet hormones and hypoglycemic agents

Candace X. Moore, Garth J. S. Cooper

Biochemical and Biophysical Research Communications

1991

151

Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures

Christine M. Mack, Candace X. Moore, Carolyn M. Jodka,

International Journal of Obesity

2006

138

Preclinical pharmacology of pramlintide in the rat: Comparisons with human and rat amylin

Andrew A. Young, William Vine, Bronislava Gedulin,

Drug Development Research

1996

133

Molecular cloning of two receptors from rat brain with high affinity for salmon calcitonin

K Albrandt, Emily Mull, Elize M.G. Brady,

FEBS Letters

1993

99

Molecular cloning and functional expression of a third isoform of the human calcitonin receptor and partial characterization of the calcitonin receptor gene.

K Albrandt, Emer M. Brady, Candace X. Moore,

Endocrinology

1995

83

SPECIAL REPORT Regulation of muscle glycogen metabolism by CGRP and amylin: CGRP receptors not involved

Kevin Beaumont, Richard Pittner, Candace X. Moore,

British Journal of Pharmacology

1995

41

Differential antagonism of amylin's metabolic and vascular actions with amylin receptor antagonists

Kevin Beaumont, Candace X. Moore, Richard Pittner,

Canadian Journal of Physiology and Pharmacology

1995

33

Comparison of the in vitro and in vivo pharmacology of adrenomedullin, calcitonin gene-related peptide and amylin in rats

William Vine, Kevin Beaumont, Bronislava Gedulin,

European Journal of Pharmacology

1996

19

Page 1